Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (2171)	6/16/1999 10:38:00 AM
From: JGoren	Respond to of 2539

Tsumura to Market Monsanto's Oral Contraceptive in Japan Tokyo, June 15 (Bloomberg) -- Tsumura & Co., the largest maker of traditional Japanese herbal medicines, said it reached an agreement with Monsanto Co. to sell the U.S. company's low- dose oral contraceptive in Japan. The low-dose birth control pill will receive final approval in Japan later this month, after nine years of deliberations. Nine foreign and Japanese drugmakers will start marketing their products by autumn, the Ministry of Health and Welfare said. Tsumura, which sells herbal medicines to treat gynecological diseases, will distribute and sell the Synphase oral contraceptive made by Monsanto. The two companies will cooperate in marketing. Synphase will be the first non-herbal gynecological medicine in Tsumura's line of products, the company said. Tsumura shares rose 4 yen, or 0.8 percent, to 490 yen in morning trading in Tokyo. Jun/15/1999 11:18 -------------------------------------------------------------- Japan Approves Birth-Control Pill; Sales to Begin in August Tokyo, June 16 (Bloomberg) [edited] -- Japan, the world's second- largest drug market after the U.S., formally approved the use of low-dose oral contraceptives, drugmakers said, opening the door for companies such as Schering AG, the world's biggest maker of the Pill, to begin selling the contraceptive pill. The Japanese Ministry of Health approved 16 different low-dose birth control pills, which will be marketed by nine companies. Estimates are that about 7 percent of Japanese women aged between 20 and 39 eventually will use birth-control pills. That represents a market of about 45 billion yen ($370 million) annually.

To: Anthony Wong who wrote (2171)	6/16/1999 12:28:00 PM
From: Dan Spillane	Read Replies (2) \| Respond to of 2539

Well, Shapiro probably knows better than anyone else how ugly agricultural trade problems can be. And such problems have plagued the world for some time, even before the current set. RE: Clinton Appoints New Members to Advisory Committee for Trade Policy and Negotiations To: National Desk Contact: White House Press Office, 202-456-2100 WASHINGTON, June 15 /U.S. Newswire/ -- President Clinton today announced his intent to appoint Thomas J. Donohue, Gerald Greenwald, Louis V. Gerstner Jr., Rhonda Karpatkin, and Robert Shapiro to be members of the Advisory Committee for Trade Policy and Negotiations (ACTPN).